Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's doxycycline
monohydrate 100 mg tablets to Par's Adoxa® 100 mg tablets following a single, oral 100 mg (1
x 100 mg) dose administered under fasting conditions.